These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7654449)

  • 81. [Antisense nucleic acids and gene therapy].
    Saison-Behmoaras E
    Bull Cancer; 1995 Mar; 82(3):224-5. PubMed ID: 7655155
    [No Abstract]   [Full Text] [Related]  

  • 82. 10 years and counting: the hype and hope of cancer biotechnology.
    Morris K
    Lancet Oncol; 2002 Oct; 3(10):582. PubMed ID: 12372706
    [No Abstract]   [Full Text] [Related]  

  • 83. European School of Oncology Task Force Papers: gene therapy--a future in cancer management? Antisense therapy for malignant disease.
    O'Brien SG; Kirkland MA; Goldman JM
    Eur J Cancer; 1994; 30A(8):1160-4. PubMed ID: 7654449
    [No Abstract]   [Full Text] [Related]  

  • 84. Antisense oligonucleotides as therapeutic agents.
    Alama A; Barbieri F; Cagnoli M; Schettini G
    Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antisense oligonucleotides in cancer.
    Castanotto D; Stein CA
    Curr Opin Oncol; 2014 Nov; 26(6):584-9. PubMed ID: 25188471
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gene-modified cells for the treatment of cancer.
    Whartenby KA; Abraham GN; Calabresi PA; Abboud CN; Calabresi P; Marrogi A; Freeman SM
    Pharmacol Ther; 1995 Apr; 66(1):175-90. PubMed ID: 7630929
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cancer gene therapy: Part 2. Candidate transgenes and their clinical development.
    Harrington KJ; Melcher AA; Bateman AR; Ahmed A; Vile RG
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):148-69. PubMed ID: 12069125
    [No Abstract]   [Full Text] [Related]  

  • 88. [The significance of specific oligonucleotides in clinical medicine and their use in the treatment of patients with infective diseases].
    Bojić I
    Vojnosanit Pregl; 1996; 53(5):399-408. PubMed ID: 9229959
    [No Abstract]   [Full Text] [Related]  

  • 89. Molecular approaches to cancer therapy.
    Israel MA
    Adv Cancer Res; 1993; 61():57-85. PubMed ID: 8346720
    [No Abstract]   [Full Text] [Related]  

  • 90. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antisense oligonucleotides: a new therapeutic approach.
    Temsamani J; Guinot P
    Biotechnol Appl Biochem; 1997 Oct; 26(2):65-71. PubMed ID: 9357101
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gene therapy for cancer.
    Kipps TJ
    J Hematother; 1993; 2(3):367-72. PubMed ID: 7921998
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antisense therapy in oncology: new hope for an old idea?
    Tamm I; Dörken B; Hartmann G
    Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.